Association between polymorphisms in TYMS gene and outcomes of hepatocellular carcinoma patients treated with transarterial chemoembolization
10.3969/j.issn.1002-1671.2015.10.029
- VernacularTitle:胸苷酸合成酶 SNP 与肝癌介入治疗患者预后的相关性分析
- Author:
Chao LI
;
Rui LU
;
Xu GUO
;
Zhaoyong YAN
;
Peng YUAN
;
Huiqing ZHANG
;
Hui ZHANG
;
Hongxin ZHANG
- Publication Type:Journal Article
- Keywords:
hepatocellular carcinoma;
single nucleotide polymorphism;
prognosis;
association analysis
- From:
Journal of Practical Radiology
2015;(10):1687-1691,1730
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the correlation between functional single nucleotide polymorphisms (SNPs)in TYMS gene and the prognosis of hepatocellular carcinoma (HCC)patients treated with transcatheter arterial chemoembolization (TACE).Methods Five functional SNPs in TYMS gene were genotyped in a cohort of 41 9 unresectable Chinese HCC patients treated with TACE and prognosis analysis was performed.Results No SNP significantly associated with OS of HCC,but in patients with only TACE treat-ment,SNPs rs523230 exhibited significant associations with death risk in HCC patients under the additive model.Patients over 60 years old,SNP rs9967368 exhibited significant associations with death risk in HCC patients under the recessive model.Conclusion Genetic variations in TYMS gene may be a potential biomarker for predicting clinical outcome of HCC patients treated with TACE.